SPL 0.00% 9.5¢ starpharma holdings limited

Ann: Positive DEP irinotecan clinical results presentation, page-17

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,805 Posts.
    lightbulb Created with Sketch. 322
    More than than Capt'n…

    ”Multiple patients have also provided positive feedback about the improved quality of life experienced with DEP® irinotecan compared to conventional irinotecan therapy.”

    Living with cancer is no fun.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.